AMTA Conference Comittee


Conference 2000
American Methadone Treatment Association
April 9-12, 2000
San Francisco

Committee Chair John Finger


Committee Members

Assistant to the Chair, Michael Garrett
Co-chair, Alice Diorio

Committee

James DePasquale
Becky Duarte
Barbara Finger
Carlos Franco
Greg Keller

Howard Lotsof
Judith Ostergard
Carmen Pearman
Diane Seaman
Joycelyn Woods

NAMA Events and Activities

Exhibition Booth

Booth Manager: Greg Keller, WI NAMA

Visit NAMA at the Consumer Advocacy Booth during the conference. NAMA would like to thank AFIRM for the donation of the booth.

NAMA Preconference Meeting

How Can We Develop and Strengthen Patient Advocacy Groups?

Day: Sunday
Date: April 9, 2000
Time: 1 – 5 PM

Moderator: John Finger, TexNAMA

Presenters:
Joycelyn Woods, NAMA
Diane Fleury-Seaman, MALTA
Fred Christie, AFIRM
James DePasquale, Membership Director/Chapter Coordinator of NAMA

This special preconference meeting has been developed by the National Alliance of Methadone Advocates (NAMA) in collaboration with other advocacy groups to present concepts that programs can use to promote positive patient outcomes and consumer satisfaction that will be a major focus for the new accreditation system. Ways for providers to develop consumer satisfaction including patient recognition ceremonies, 12 step groups, patient advisory boards, patient advocacy groups and patient organizing drives are some of the strategies that can be utilized by providers and patients to work together and the enormous benefits that will come from this. The intended audience for this presentation includes program directors, medical personnel, doctors, nurses, counselors, social workers, administrative staff, patients, advocates and anyone else included in the methadone field. This meeting will greatly enhance the ability of providers and patients to become one community with the common goal of creating the best methadone system possible.

Supported by the Center for Substance Abuse Treatment

Conference Workshops

D4

Planting the Seeds and Watching the Patients Grow

Day: Tuesday
Date: April 11 2000
Time: 1 – 2:30 PM

Presenters:
Alice Diorio
New England Chapter/National Alliance of Methadone Advocates (NENAMA)
Diane Fleury-Seaman, S.D.C.
Methadone as a Legitimate Treatment Alternative (MALTA)
John McCarthy, M.D.
Bi-Valley Medical Clinic (NAMA Advisory Board)

This interactive workshop uses harm reduction principles and sensitivity training to improve outcomes. Presenters will give a patient’s perspective on how to create individualized treatment based on communication and respect. They will discuss ways to enhance a trusting, therapeutic relationship that conveys compassion and understanding.

NAMA Organization Meeting

To be determined.

Visit the AMTA website at www.assnmethworks.org


Visit the Events Page


Last Update: January 27, 2000


Home

Similar Posts

  • The National Methadone Conference-1

    Admin 11/09/2022

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Organizational Meeting April 15, 2003 Picture Essay of NAMA’s Organizational Meeting Starting the Meeting Joyce calls the meeting to order. Top (l-r) Robert Sanders (NYC NAMA), Becki Ballard (OK NAMA), Gary Nessenbaum (WAMM), Jennifer Nelson Connelly (PA NAMA), Joycelyn Woods,…

  • Remember Us!

    Admin 06/03/2021

    The Writer Asks to Have Their Name Withheld for Fear of Retaliation Imagine — a young woman is in the Ladies Room stall, the Door is being held open by a worker whose job it is to observe the woman (any female patient) give a urine sample. This sample is tested for any drugs that…

  • |

    FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction Drug

    Admin 03/17/2023

    FDA Talk Paper April 20, 2001 T01-15 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The FDA is strengthening warnings to physicians about serious cardiac adverse events associated with Orlaam (levomethadyl acetate HC), a drug for opiate addiction treatment. FDA has changed the Orlaam labeling to increase the strength of the warnings and to…

  • Letter to Senator McCain

    Admin 02/05/2023

    March 3, 1999   Dear Senator McCain: Your introduction of Senate Bill 423 is disheartening. That someone with such an esteemed position as senator would base public policy on the hearsay of a proselytizer instead of sound and extensive scientific evaluations is wrong. It is unfortunate that our government once primarily composed of statesmen today…

  • |

    Publication

    Admin 03/31/2021

    Sniffing, Snorting Drugs May Raise HCV Risk by Theresa Waldron Reuters Health 4 Jul. 2003 Source: Journal of Medical Virology. 2003;70:387-390. People who snort or sniff heroin in combination with cocaine may be at increased risk of developing the liver infection hepatitis C, according to a new study. Thomas Kresina, a spokesman for the National…

  • Methadone Advocacy

    Admin 04/11/2021

      The National Alliance of Methadone Advocates (nama) holds the view that every individual who believes in methadone treatment is at least a potential Certified Methadone Advocate (CMA). We encourage all supporters of methadone treatment, patient and non-patient, to become Certified Methadone Advocates so that all energies directed toward the advancement of methadone treatment produce…